CT laser mammography (CTLM) developer Imaging Diagnostic Systems (IDSI) of Fort Lauderdale, FL, announced that Charité Medical University in Berlin has begun a clinical study of its breast imaging technology.
The study will examine the potential role of IDSI's model 1020 CTLM laser breast imaging system as an enhanced breast cancer screening tool when used in combination with indocyanine green (ICG) fluorescent dye. The study will be conducted at Charité's Campus Virchow-Klinikum under principal investigator Dr. Alexander Poellinger.
Poellinger and colleagues hope that by using a fluorescent dye in a clinical breast cancer study they can demonstrate an enhancement of the sensitivity and the specificity of diffuse optical tomography. They will be using a modified CTLM breast scanner that is capable of acquiring both absorption and fluorescence images.
Related Reading
IDSI hires strategic advisor, June 11, 2009
IDSI appoints managing director for India, April 30, 2009
IDSI names Italian distributor, April 29, 2009
IDSI taps Eastern European distributor, April 28, 2009
IDSI renews Polish distributorship, April 17, 2009
Copyright © 2009 AuntMinnie.com
